Full-Time

Senior Quality Operations Specialist

Curia

Curia

1,001-5,000 employees

End-to-end drug development and manufacturing

No salary listed

Albuquerque, NM, USA

In Person

Bachelor's

Category
Biology & Biotech (1)

Get referred to Curia

See people who can refer or advise you

Requirements
  • Bachelor's degree (BS or BA) in Chemistry, Biology, Microbiology, Engineering, Pharmaceutical Sciences or a related scientific discipline from a four-year accredited college or university
  • Minimum of eight (8) years of progressive experience in the pharmaceutical, biologics, biotechnology, or related regulated industry, with significant experience in Quality Assurance, Validation activities, Engineering Quality, Manufacturing Quality or Regulatory Compliance.
  • Demonstrated experience providing Quality Assurance oversight and approval of validation lifecycle activities, including equipment qualification, facility and utility qualification, process validation, cleaning validation, computerized systems validation and commissioning activities.
  • Demonstrated experience reviewing and approving quality system records, including validation protocols and reports, change controls, deviations, CAPAs, risk assessments and controlled GMP documentation.
  • Strong working knowledge of current cGMP regulations, industry guidance and regulatory expectations associated with pharmaceutical and/or biologics manufacturing operations.
  • Experience supporting facility expansions, capital projects, technology transfers, equipment implementation, and manufacturing process improvements within a regulated environment.
  • Demonstrated ability to apply risk-based decision making, interpret regulatory requirements and provide independent quality guidance to cross-functional teams.
  • Experience in aseptic manufacturing, biologics manufacturing and/or contract development and manufacturing (CDMO) environments is strongly preferred.
Responsibilities
  • Serve as the Quality Assurance subject matter expert and quality approver for validation, qualification, commissioning, engineering, facilities, utilities, computerized systems and manufacturing-related activities.
  • Provide independent quality oversight and approval of validation lifecycle deliverables, including protocols, reports, deviations, change controls, risk assessments, commissioning documents, Validation Master Plans and associated controlled records.
  • Ensure validation and qualification activities are designed and executed in compliance with applicable cGMP regulations, company procedures, regulatory expectations, and industry best practices.
  • Partner with Engineering, Validation, Facilities, Manufacturing, Technical Operations, and other functional groups to provide quality guidance and oversight for capital projects, facility expansions, equipment installations, process improvements and technology transfers.
  • Assess quality and compliance risks associated with validation, engineering and manufacturing activities and provide risk-based recommendations to support sound business and quality decisions.
  • Review and approve qualification, validation, requalification, and revalidation documentation for facilities, utilities, equipment, manufacturing processes and computerized systems.
  • Provide quality oversight for the development, revision, and maintenance of Validation Master Plans, validation strategies and technical documentation supporting regulatory submissions and commercial manufacturing operations.
  • Lead and support investigations related to validation, qualification and engineering activities, ensuring appropriate root cause analysis, impact assessments, corrective actions and effectiveness verification.
  • Support inspection readiness activities and serve as a quality representative during customer audits, regulatory inspections and due diligence assessments related to validation, facilities, engineering and manufacturing systems.
  • Provide technical expertise and guidance regarding quality systems, validation principles, data integrity requirements and regulatory expectations to cross-functional teams.
  • Identify opportunities to improve validation compliance, quality system effectiveness, and operational efficiency through continuous improvement initiatives and implementation of industry best practices.
  • Monitor emerging regulatory requirements and industry trends and assess applicability to site validation and quality systems.
  • Act as a mentor and technical resource for colleagues by sharing expertise, providing consultation and promoting a culture of compliance and quality excellence.
  • Maintain current training requirements and remain knowledgeable of applicable regulations, guidance documents, and company procedures.
  • Perform other duties as assigned
Desired Qualifications
  • Experience supporting customer audits, regulatory inspections and responses to compliance observations is preferred.
  • Experience in aseptic manufacturing, biologics manufacturing and/or contract development and manufacturing (CDMO) environments is strongly preferred

Curia is a contract development and manufacturing organization (CDMO) that partners with pharmaceutical and biotech companies to move medical breakthroughs from concept to market. It provides end-to-end services across the drug development lifecycle, including early research, method development and validation, preformulation, material science, solid-state chemistry, and package device testing. Revenue comes from service contracts for specialized capabilities and expertise, with clients ranging from small startups to large pharma. Curia also collaborates with industry leaders to advance continuous flow development and manufacturing programs. The company differentiates itself through flexible and scalable solutions, deep scientific expertise, and state-of-the-art technology that help clients accelerate development timelines while navigating discovery to commercialization. Its goal is to enable efficient, reliable progression of drug candidates from conception through to market approval.

Company Size

1,001-5,000

Company Stage

Debt Financing

Total Funding

$132M

Headquarters

Albany, New York

Founded

1991

Get referred to Curia

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Albuquerque’s $200 million expansion adds commercial drug-product capacity during 2025-2026.
  • Glasgow’s upgrade reaches early 2027, expanding batches to 20,000 vials.
  • March 2025 refinancing and July 2026 recapitalization inject capital for near-term execution.

What critics are saying

  • Apollo-led recapitalization on July 8, 2026 signals strained leverage and lender control.
  • Curia will close Burlington by June 1, 2026, cutting 81 jobs and shrinking capacity.
  • Octus reported June 2, 2026 out-of-court restructuring talks; a failed process risks insolvency.

What makes Curia unique

  • Curia spans discovery through commercial fill-finish across 20+ sites, rare among CDMOs.
  • Glasgow and Albuquerque expansions deepen sterile injectables capacity, including Annex 1 isolator lines.
  • Hopkinton CLD upgrades deliver sixfold higher titers, strengthening biologics process-development economics.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Paid Vacation

401(k) Retirement Plan

401(k) Company Match

Tuition Reimbursement

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Carlyle
Jan 30th, 2026
AMRI Announces Completion of Acquisition by The Carlyle Group and GTCR | Carlyle

ALBANY, N.Y. – Albany Molecular Research, Inc. (NASDAQ:AMRI), a global contract research, development and manufacturing organization working with the life sciences industry to improve patient outcomes and quality of life for more than 25 years, today announced the completion of its previously announced acquisition by affiliates of The Carlyle Group (“Carlyle”) and affiliates of GTCR LLC (“GTCR”). President and Chief Executive Officer William S. Marth will continue to lead AMRI.

BERNAMA
May 10th, 2024
BIOLOGICS SYMPOSIUM: CURIA, CARTERRA PARTNER TO ADVANCE BIOTECH RESEARCH IN PACIFIC NORTHWEST

KUALA LUMPUR, May 10 (Bernama) - Curia, a contract research, development and manufacturing organisation (CDMO) has announced a partnership with Carterra Inc in hosting a high-throughput biologics symposium slated for May 31, in Seattle, Washington.

PharmiWeb
Mar 14th, 2024
Pace® Life Sciences Acquires New Jersey Laboratory From Curia

Former Whitehouse Analytical Laboratory is Now Part of the Pace® Laboratory Network

Pakistan Press International
Feb 23rd, 2024
Curia Appoints Steve Lavezoli as Vice President, Biologics

ALBANY, N.Y., Feb. 23, 2024 (GLOBE NEWSWIRE) - Curia, a leading contract research, development and manufacturing organization, today announced it has appointed Steve Lavezoli as vice president of biologics effective Feb. 26.

Cameroon Online News
Feb 5th, 2024
Curia Receives 2024 CDMO Leadership Award

Curia was awarded based on the feedback of respondents in the Small Pharma category.